Publications by authors named "Thomas Quinten"

Claim this Profile
3
3D-printed biomaterial-based scaffolds loaded with zoledronic acid functionalised ceramic microparticles for sustained release.
Aikaterini Dedeloudi, Laura Martinez-Marcos, Thomas Quinten, Sune K Andersen, Dimitrios A Lamprou

Int J Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Bioceramic Bone-Inspired Scaffolds Through Single-Step Melt-Extrusion 3D Printing for Segmental Defect Treatment.
Aikaterini Dedeloudi, Pietro Maria Bertelli, Laura Martinez-Marcos, Thomas Quinten, Imre Lengyel

J Funct Biomater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopolymeric 3D printed implantable scaffolds as a potential adjuvant treatment for acute post-operative pain management.
Aikaterini Dedeloudi, Laura Martinez-Marcos, Thomas Quinten, Sune Andersen, Dimitrios A Lamprou

Expert Opin Drug Deliv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of 3D printing in early phase development of pharmaceutical solid dosage forms.
Rachel L Milliken, Thomas Quinten, Sune K Andersen, Dimitrios A Lamprou

Int J Pharm· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a new age-appropriate, chewable tablet of mebendazole 500 mg for preventive chemotherapy of soil-transmitted helminth infections in pre-school and school-age children.
Ben Van Hove, Pritam Kanagale, Thomas Quinten, Sheetal Gaiki, Karin Collignon

Eur J Pharm Biopharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-line NIR spectroscopy for the understanding of polymer-drug interaction during pharmaceutical hot-melt extrusion.
Lien Saerens, Lien Dierickx, Thomas Quinten, Peter Adriaensens, Robert Carleer

Eur J Pharm Biopharm· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
Thomas Quinten, Yves Gonnissen, Els Adriaens, Thomas De Beer, Veerle Cnudde

Eur J Pharm Sci· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Thomas Quinten, Thomas De Beer, Chris Vervaet, Jean Paul Remon

Eur J Pharm Biopharm· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis